Xbrane Biopharma invites to a company presentation at Redeye Growth day, 10th June, Stockholm.

English

News

Xbrane Biopharma and Redeye invites to a company presentation at Haymarket by Scandic, Hötorget 13-15 in Stockholm on the 10th of June, between 08.00-17.30 CEST.

Xbrane Biopharma will be represented by CEO Martin Åmark and the presentation will be broadcasted live. Xbrane´s presentation starts at 13.40 CEST and to see the live broadcast, follow the link below;

Live broadcast

About Us

Xbrane is a commercial phase Swedish biopharmaceutical company specialized in biosimilars. Xbrane has a patented protein production platform for development of biosimilars and world leading expertise in biosimilars. Xbrane’s headquarter is located in Solna outside of Stockholm and the company’s in-house research and development facilities are in Sweden and Italy. Xbrane is listed at Nasdaq First North since February 3rd, 2016 under the name XBRANE and Avanza Bank AB is Xbrane’s certified adviser (corp@avanza.se, +46 (0)8 409 421 20).
For more information see www.xbrane.com.